Evolving concepts in dilated cardiomyopathy

Marco Merlo1, Antonio Cannatà1, Marco Gobbo1

  • 1Cardiovascular Department 'Ospedali Riuniti' and University of Trieste, Trieste, Italy.

Insights

Dilated cardiomyopathy (DCM) is a genetic heart failure often affecting young people. Advances improve prognosis, but key management questions regarding diagnosis, genotype-phenotype links, and arrhythmia risk remain.

Area of Science:

  • Cardiology
  • Genetics
  • Heart Failure

Background:

  • Dilated cardiomyopathy (DCM) is a primary cause of systolic heart failure, often with a genetic basis.
  • It typically affects younger individuals with minimal comorbidities.
  • Prognosis has improved due to better etiological understanding and integrated care.

Purpose of the Study:

  • To provide a comprehensive review of current clinical management of DCM.
  • To address unresolved issues in DCM diagnosis and risk stratification.
  • To offer practical recommendations for managing DCM.

Main Methods:

  • Literature review of recent advancements in DCM.
  • Analysis of emerging issues in clinical management.
  • Synthesis of evidence for practical recommendations.

Main Results:

  • DCM management has advanced through etiological characterization and systematic screening.
  • Key challenges persist in cardiac magnetic resonance utility, genotype-phenotype correlations, and arrhythmia risk assessment.
  • The dynamic nature of DCM necessitates ongoing treatment optimization.

Conclusions:

  • Despite improved outcomes, critical management aspects of DCM require further investigation.
  • Addressing unresolved issues like advanced imaging and genetic insights is crucial.
  • Continuous optimization of evidence-based treatments is essential for DCM patients.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
594
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
629
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
611